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1. INTRODUCTION {#anec12750-sec-0005}
===============

Fragmented QRS (fQRS) is often caused by myocardial scarring with consequent heterogeneous ventricular activation and dyssynchronous contraction of the ventricles.(Basaran et al., [2011](#anec12750-bib-0001){ref-type="ref"}) Several studies have shown that fQRS is commonly generated after myocardial infarction and reflects the varying conduction abnormalities and the delay of peri‐infarct area conductions due to myocardial necrosis or scarring. Fragmented QRS has been shown to appear 24--48 hr after onset of ACS symptoms.(Das, Khan, Jacob, Kumar, & Mahenthiran, [2006](#anec12750-bib-0005){ref-type="ref"}) It has been previously shown that increased fragmentation of QRS wave was associated with previous myocardial infarction, ventricular enlargement, and decreased LVEF.(Sha et al., [2011](#anec12750-bib-0011){ref-type="ref"}).

Cardiac resynchronization therapy (CRT) is an integral mode of intervention in patients with heart failure (HF) with reduced ejection fraction and was associated with reduced morbidity and mortality in appropriate patients.(Ponikowski et al., [2016](#anec12750-bib-0009){ref-type="ref"}; Yancy et al., [2017](#anec12750-bib-0017){ref-type="ref"}) Usually these patients have wide QRS, and the guidelines also adhere to the QRS duration. However, studies have shown that up to 50% of patients with HF and normal QRS duration has mechanical ventricular dyssynchrony, and these patients may benefit from CRT (Dohi, Suffoletto, Murali, Bazaz, & Gorcsan, [2005](#anec12750-bib-0007){ref-type="ref"}; Yu et al., [2006](#anec12750-bib-0018){ref-type="ref"}). There is the need for other methods of assessment other than QRS duration, although whether the benefit of CRT in normal QRS duration with dyssynchrony is not the scope of our study. Nonresponsiveness to CRT is also problematic; approximately 30% of those implanted with CRT did not respond well to the treatment (Bax et al., [2004](#anec12750-bib-0002){ref-type="ref"}; Yu et al., [2005](#anec12750-bib-0019){ref-type="ref"}). This leads to a costly procedure without apparent benefit and increased risk of other complications related to CRT.

Fragmented QRS is postulated to be one of the markers to fill these gaps in selective patients; it was thought to be associated with ventricular dyssynchrony and might be able to predict a nonresponse to CRT implantation. In this systematic review and meta‐analysis, we aim to assess (a) fQRS as a marker of intraventricular dyssynchronies in patients with ischemic and nonischemic cardiomyopathy and (b) whether fQRS is an independent predictor of nonresponse in patients receiving CRT.

2. METHODS {#anec12750-sec-0006}
==========

2.1. Search strategy {#anec12750-sec-0007}
--------------------

We performed a comprehensive search on topics that assesses fQRS and its association with intraventricular dyssynchrony and nonresponse to CRT with keywords ("fragmented QRS" and "dyssynchrony" OR "cardiac resynchronization therapy") and its synonym from inception up until September 2019 through PubMed, Europe PMC, Cochrane Central Database, and hand sampling from potential articles cited by other studies. The records were then systematically evaluated using inclusion and exclusion criteria. We also perform hand sampling from references of the included studies. Two researchers (A.E.T and R.V) independently performed an initial search, and discrepancies were resolved by discussion. A Preferred Reporting Items for Systematic Reviews and Meta‐Analyses flowchart of the literature search strategy of studies was presented in Figure [1](#anec12750-fig-0001){ref-type="fig"}.

![Study flow diagram](ANEC-25-e12750-g001){#anec12750-fig-0001}

2.2. Selection criteria {#anec12750-sec-0008}
-----------------------

The inclusion criteria for this study are all studies that assess fQRS, intraventricular dyssynchrony, and nonresponse to CRT. We include all related clinical researches/original articles and exclude case reports, review articles, and non‐English language articles.

2.3. Data extraction {#anec12750-sec-0009}
--------------------

Data extraction and quality assessment were done by two independent authors (E.Y and R.P) using standardized extraction form which includes authors, year of publication, study design, subject characteristics, study definition of dyssynchrony and nonresponse to CRT, sample size, QRS duration, prevalence of fQRS, and follow‐up duration.

2.4. Statistical analysis {#anec12750-sec-0010}
-------------------------

To perform the meta‐analysis, we used RevMan version 5.3 software (Cochrane Collaboration) and STATA/MP 14 (StataCorp LLC). We used the odds ratio (OR) and a 95% CI as a pooled measure for dichotomous data. We used mean difference and its standard deviation (*SD*) as a pooled measure for the continuous data. Inconsistency index (*I* ^2^) test, which ranges from 0% to 100%, was used to assess heterogeneity across studies. A value above 50% or *p* \< .05 indicates statistically significant heterogeneity. We used the Mantel--Haenzsel or inverse variance (for adjusted OR) method for OR and inverse variance for mean difference with a fixed‐effect model for meta‐analysis, and a random‐effect model was used in case of heterogeneity if appropriate. All *p* values were two‐tailed with a statistical significance set at .05 or below. We also perform sensitivity analysis and subgroup analysis whenever possible/appropriate.

3. RESULTS {#anec12750-sec-0011}
==========

We found a total of 3,049 results on the initial search. There were 3,021 records after removal of duplicates. A total of 3,011 records were excluded after screening the title/abstracts. After assessing ten full texts for eligibility, we excluded two because of no control group. We included eight studies in qualitative synthesis and seven studies meta‐analysis (Celikyurt et al., [2013](#anec12750-bib-0003){ref-type="ref"}, [2012](#anec12750-bib-0004){ref-type="ref"}; Hu et al., [2019](#anec12750-bib-0008){ref-type="ref"}; Rad et al., [2015](#anec12750-bib-0010){ref-type="ref"}; Sinha et al., [2016](#anec12750-bib-0012){ref-type="ref"}; Tigen et al., [2009](#anec12750-bib-0014){ref-type="ref"}; Yusuf et al., [2013](#anec12750-bib-0021){ref-type="ref"}; Zhao et al., [2015](#anec12750-bib-0022){ref-type="ref"}) (Figure [1](#anec12750-fig-0001){ref-type="fig"}). One study was excluded from meta‐analysis because it has different definition of nonresponder outcome that being "Cardiac death, heart transplantation, or HF hospitalization." Four studies were prospective cohorts, three were cross‐sectional, and one was retrospective cohort. There were a total of 864 subjects from eight studies. (Table [1](#anec12750-tbl-0001){ref-type="table"}).

###### 

Studies included in the systematic review

<table><thead><tr class="header"><th>Study</th><th>Design</th><th>Patient characteristics</th><th>Definition of dyssynchrony</th><th>Definition of nonresponse</th><th>Samples</th><th>Nonischemic CM</th><th>QRS duration (ms)</th><th><p>QRS duration</p><p>(fQRS vs. non‐fQRS)</p></th><th>fQRS+</th><th>Follow‐up</th></tr></thead><tbody><tr class="odd"><td>Hu et al., <a href="#anec12750-bib-0008" data-ref-type="ref">2019</a></td><td>Retrospective Cohort</td><td><p>Reduced LVEF who</p><p>successfully underwent CRT implantation</p></td><td>N/A</td><td><p>Cardiac death, heart transplantation,</p><p>or HF hospitalization during 1‐year follow‐up</p></td><td>296</td><td>81.4%</td><td>166.7 ± 18.5</td><td>N/A</td><td>61 (20.6%)</td><td>12 months</td></tr><tr class="even"><td>Sinha et al., <a href="#anec12750-bib-0012" data-ref-type="ref">2016</a></td><td>Cross‐sectional</td><td><p>Chronic HF</p><p>due to nonischemic DCM,</p><p>LVEF ≤ 35% and normal sinus rhythm</p><p>having narrow QRS complexes (≤ 120 ms)</p></td><td>Ts‐<em>SD</em> &gt; 32.6 ms</td><td>N/A</td><td>226</td><td>100%</td><td>96.7 ± 15</td><td>102.42 ± 14.05/91.10 ± 13.75</td><td>112 (49.5%)</td><td>N/A</td></tr><tr class="odd"><td>Zhao et al., <a href="#anec12750-bib-0022" data-ref-type="ref">2015</a></td><td>Prospective Cohort</td><td><p>Idiopathic DCM</p></td><td><p>time in peak anteroseptal wall to posterior wall</p><p>strain &gt; 130 ms or longitudinal strain delay index &gt; 25%</p></td><td>N/A</td><td>49</td><td>100%</td><td>100.7 ± 8.5</td><td>101.5 ± 9.3/98.6 ± 6.7</td><td>20 (40.8%)</td><td>24 months</td></tr><tr class="even"><td>Rad et al., <a href="#anec12750-bib-0010" data-ref-type="ref">2015</a></td><td>Prospective Cohort</td><td>HF undergoing CRT implantation</td><td>N/A</td><td><p>&lt;15%</p><p>decrease in LVESV at follow‐up</p></td><td>65</td><td>9%</td><td>139.5 ± 12.7</td><td>142.6 ± 13.5/137.4 ± 11.8</td><td>27 (41.5)</td><td>6 months</td></tr><tr class="odd"><td>Celikyurt et al., <a href="#anec12750-bib-0003" data-ref-type="ref">2013</a></td><td>Prospective Cohort</td><td>HF undergoing CRT implantation</td><td>N/A</td><td><p>&lt;15%</p><p>decrease in LVESV at follow‐up</p></td><td>105</td><td>61%</td><td>146 ± 18</td><td>N/A</td><td>48 (46%)</td><td>6 months</td></tr><tr class="even"><td>Yusuf et al., <a href="#anec12750-bib-0021" data-ref-type="ref">2013</a></td><td>Prospective Cohort</td><td><p>Chronic HF</p><p>due to nonischemic DCM,</p><p>LVEF &lt; 35% and normal sinus rhythm</p><p>having narrow QRS complexes (&lt; 120 ms)</p></td><td>Ts‐<em>SD</em> &gt; 32.6 ms</td><td>N/A</td><td>100</td><td>100%</td><td>94.8 ± 14.1</td><td>99.42 ± 13.05/90.10 ± 13.75</td><td>50 (50%)</td><td>N/A</td></tr><tr class="odd"><td>Celikyurt et al., <a href="#anec12750-bib-0004" data-ref-type="ref">2012</a></td><td>Prospective Cohort</td><td>HF with a wide QRS complex undergoing CRT implantation</td><td><p>IVMD ≥ 40 ms and tissue Doppler velocity</p><p>opposing‐wall delay ≥ 65 ms</p></td><td><p>&lt;15%</p><p>decrease in LVESV at follow‐up</p></td><td>53</td><td>63.8%</td><td>139.6 ± 15.9</td><td>143 ± 13/138 ± 17</td><td>17 (32.1%)</td><td>6 months</td></tr><tr class="even"><td>Tigen et al., <a href="#anec12750-bib-0014" data-ref-type="ref">2009</a></td><td>Cross‐sectional</td><td><p>Nonischemic DCM with</p><p>sinus rhythm and narrow QRS</p></td><td><p>Max‐ASE Sys and Max‐ASE Dias of more than 100 ms,</p><p>and Max‐ASE to Mean Sys of more than 60 ms</p></td><td>N/A</td><td>60</td><td>100%</td><td>N/A (Narrow)</td><td>N/A</td><td>20 (33.3%)</td><td>N/A</td></tr></tbody></table>

Abbreviations: CRT, cardiac resynchronization therapy; DCM, dilated cardiomyopathy; HF, heart failure; IVMD, interventricular mechanical delay; LVEF, left ventricular ejection fraction; N/A, not assessed/available/applicable; Ts‐*SD*, time‐to‐peak myocardial sustained systolic and its standard deviation.
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3.1. Characteristics of the study {#anec12750-sec-0012}
---------------------------------

Some of the studies enrolled patients with a narrow QRS complex exclusively. There are four studies that enroll nonischemic cardiomyopathy only, and there are four studies that enroll ischemic and nonischemic cardiomyopathy. The definition of dyssynchrony varied across studies. Cohorts have follow‐up ranging from 6 months to 24 months.

3.2. Fragmented QRS and intraventricular dyssynchrony {#anec12750-sec-0013}
-----------------------------------------------------

Fragmented QRS has a pooled OR of 10.34 \[3.39, 31.54\], *p* \< .001; *I* ^2^: 80%, *p* \< .001 (Figure [2](#anec12750-fig-0002){ref-type="fig"}a) for intraventricular dyssynchrony. Fragmented QRS has a sensitivity 76.8%, specificity 77%, LR + 3.3, and LR‐ 0.3 for predicting intraventricular dyssynchrony (Figure [2](#anec12750-fig-0002){ref-type="fig"}b). Upon sensitivity analysis by removing Celikyurt et al. ([2012](#anec12750-bib-0004){ref-type="ref"} study, pooled OR of 19.97 \[12.12, 32.92\], *p* \< .001; *I* ^2^: 0%, *p* = .92.

![Fragmented QRS and intraventricular dyssynchrony. Fragmented QRS was associated with intraventricular dyssynchrony (a) and has sensitivity 76.8% and specificity 77% (b). Fragmented QRS was associated with intraventricular dyssynchrony upon subgroup analysis on patients with narrow QRS complex (c) and nonischemic cardiomyopathy (d). Nonischemic cardiomyopathy subgroup has sensitivity 84.8% and specificity 77.7% (e)](ANEC-25-e12750-g002){#anec12750-fig-0002}

Subgroup analysis on patients with narrow QRS complex showed that fQRS was associated with intraventricular dyssynchrony (OR 20.92 \[12.24, 35.73\], *p* \< .001; *I* ^2^: 0%, *p* = .88) (Figure [2](#anec12750-fig-0002){ref-type="fig"}c). Subgroup analysis on nonischemic cardiomyopathy showed an OR of 19.97 \[12.12, 32.92\], *p* \< .001; *I* ^2^: 0%, *p* = .92 (Figure [2](#anec12750-fig-0002){ref-type="fig"}d); and sensitivity 84.8%, specificity 77.7%, LR+ 3.82, and LR− 0.19 (Figure [2](#anec12750-fig-0002){ref-type="fig"}e).

Fragmented QRS was also associated with a higher time‐to‐peak myocardial sustained systolic and its standard deviation (Ts‐*SD*) (OR 15.19 \[12.58, 17.80\], *p* \< .001; *I* ^2^: 0%, *p* = 1) and positive Yu index (OR 15.61 \[9.07, 26.86\], *p* \< .001; *I* ^2^: 0%, *p* = .46).

3.3. Fragmented QRS and nonresponse to cardiac resynchronization therapy {#anec12750-sec-0014}
------------------------------------------------------------------------

Fragmented QRS has a pooled adjusted OR of 1.70 \[1.35, 2.14\], *p* \< .001; *I* ^2^: 62%, *p* = .11 for association with a nonresponse to CRT (Figure [3](#anec12750-fig-0003){ref-type="fig"}). Hu et al. have a different definition of nonresponse to CRT that being "Cardiac death, heart transplantation, or HF hospitalization" and hence excluded in the meta‐analysis of this outcome. QRS duration is found to be higher in nonresponders group mean difference −8.54 \[−13.38, −3.70\], *p* \< .001; *I* ^2^: 70%, *p* = .07.

![Fragmented QRS and nonresponse to cardiac resynchronization therapy. Fragmented QRS was associated with nonresponse to cardiac resynchronization therapy](ANEC-25-e12750-g003){#anec12750-fig-0003}

4. DISCUSSION {#anec12750-sec-0015}
=============

Fragmented QRS is associated with intraventricular dyssynchrony, higher Ts‐*SD*, positive Yu index, and independently predicts a nonresponse to CRT. Celikyurt et al. ([2012](#anec12750-bib-0004){ref-type="ref"} study was the leading cause of heterogeneity in the meta‐analysis. This is possibly due to this being the only study which shows higher incidence of ventricular dyssynchrony after implementation on CRT on patients without fragmented QRS on ECG. Interventricular and intraventricular dyssynchrony were highly prevalent in both patient groups with fragmented QRS and without fragmented QRS (64% vs. 75%, *p* = .44; 70% vs. 72.2%, *p* = .25 Respectively). Celikyurt et al. ([2012](#anec12750-bib-0004){ref-type="ref"} also had the broadest QRS duration (139.6 ± 15.9 ms) among variables analyzed for intraventricular dyssynchrony prediction; the others were mostly narrow except one study by Zhao et al. which did not specify but has a mean duration of 100.7 ± 8.5 ms.

It is interesting to note in a study by Celikyurt et al. ([2012](#anec12750-bib-0004){ref-type="ref"} that interventricular dyssynchrony was more prevalent in patients with fragmented QRS wave while intraventricular dyssynchrony was more prevalent in patients without fragmented QRS wave. The findings of this study contradict the previous findings and hypothesis on other studies that stated fragmented QRS and its underlying electrical remodeling on ventricular wall as a predisposing factor of ventricular dyssynchrony after CRT implantation The result of study by Celikyurt et al. ([2012](#anec12750-bib-0004){ref-type="ref"} is in accordance with a study by Yu et al. ([2006](#anec12750-bib-0018){ref-type="ref"} that stated that the majority of patients with dyssynchrony would be found to have narrow QRS complex; however, systolic asynchrony is the most common findings in patients with wide QRS complex (Yu et al., [2007](#anec12750-bib-0020){ref-type="ref"}). We found this finding to be in accordance with the findings in this meta‐analysis, in the terms that patients with fragmented QRS were over 20 times more likely to suffer from intraventricular asynchrony.

The findings of our analysis on the relation of fragmented QRS with CRT responders were supported by Varma ([2009](#anec12750-bib-0016){ref-type="ref"}. It is shown in this study that the significance of fragmented QRS as a predictor of CRT responders stems from the findings that LV conduction delays and LV conductivity in patients with heart failure varied significantly with QRS configuration. It is found that LV conduction delays exceeding 100 ms were only found in 23% patients with narrow QRS configuration. The authors stated that these variations might affect CRT efficacy in patients with widened QRS configuration (Varma, [2009](#anec12750-bib-0016){ref-type="ref"}). Fragmented QRS causes heterogeneous ventricular activation along with dyssynchrony in patients with ischemic and non--ischemic cardiomyopathy, possibly impeding the efficacy of pacemaker (Basaran et al., [2011](#anec12750-bib-0001){ref-type="ref"}; Das et al., [2008](#anec12750-bib-0006){ref-type="ref"}). A higher number of leads with fQRS predict a nonresponse to CRT (Celikyurt et al., [2013](#anec12750-bib-0003){ref-type="ref"}). There are several factors such as left ventricular end‐diastolic diameter that may also affect nonresponsiveness to CRT; however, our meta‐analysis showed that the fragmented QRS is independent to other factors considered/found in the respective studies. In a study by Takenaka et al. ([2019](#anec12750-bib-0013){ref-type="ref"}, QRS widening was shown to be related to myocardial viability. The authors stated that both myocardial viability and improved electrical dyssynchrony might be essential to predict a positive response to CRT (Takenaka et al., [2019](#anec12750-bib-0013){ref-type="ref"}).

The clinical implication of this study is that fQRS can be used as a marker for intraventricular dyssynchrony for both narrow and wide QRS complex. This may potentially identify patients that will benefit from CRT, although more study is needed. Fragmented QRS was also a predictor of nonresponse in patients receiving CRT; this interpretation is limited to those with wide QRS complex. Combined with other predictors, a scoring system can be developed to better identify patients that at risk of failing to receive benefits from CRT implantation. Hence, unnecessary CRT implantation can be avoided. The interpretation of fQRS, however, was known to have a poor inter‐ and intra‐observer variability in patients with cardiomyopathy according to a study (Vandenberk et al., [2018](#anec12750-bib-0015){ref-type="ref"}).

Limitation of this systematic review and meta‐analysis includes publication bias in which studies with positive results were more likely to be published and included in this systematic review. The pooled sample size is relatively small, and the definition of intraventricular dyssynchrony and nonresponse to CRT varied between studies. Future studies can address the issues of CRT implantation in those with fQRS and narrow QRS complex; the studies in this meta‐analysis only address that fQRS is associated with intraventricular dyssynchrony but not whether they will benefit from CRT implantation. This issue should be addressed in order to see whether CRT implantation is justifiable in HF with narrow fQRS.

5. CONCLUSION {#anec12750-sec-0016}
=============

Fragmented QRS is associated with intraventricular dyssynchrony and is independently associated with nonresponse to cardiac resynchronization therapy. Further studies need to be done to address whether intraventricular dyssynchrony detected by fQRS should proceed with CRT implantation.
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